Atarax (Hydroxyzine) Dosage for Adults
For adults with anxiety and tension, the recommended dose is 50-100 mg four times daily (q.i.d.), while for pruritus from allergic conditions like chronic urticaria, the dose is 25 mg three to four times daily. 1
Standard Adult Dosing by Indication
Anxiety and Tension Relief
- 50-100 mg four times daily (q.i.d.) for symptomatic relief of anxiety and tension associated with psychoneurosis or as adjunct therapy in organic disease states where anxiety manifests 1
- Clinical studies demonstrate efficacy at 50 mg/day for generalized anxiety disorder, with significant reduction in Hamilton Anxiety Scale scores compared to placebo 2, 3
- Anxiolytic effects typically begin within the first week of treatment and are maintained throughout the treatment period 3
Pruritus Management
- 25 mg three to four times daily (t.i.d. or q.i.d.) for management of pruritus due to allergic conditions including chronic urticaria, atopic dermatitis, and contact dermatoses 1
- This lower dose is specifically recommended for histamine-mediated pruritus 1
- May be used as adjunctive therapy for opioid-induced pruritus in cancer patients, particularly when rotating from opiates to synthetic opioids is not feasible 4
Sedation/Premedication
- 50-100 mg as premedication before procedures or following general anesthesia 1
- When initiated via intramuscular route, subsequent doses may be administered orally 1
Critical Dosing Considerations
Elderly Patients
- Lower doses are strongly recommended due to increased risk of anticholinergic effects, sedation, and cognitive impairment 5
- The long half-life of 20 ± 4.1 hours increases risk of drug accumulation with repeated dosing in elderly patients 5
- Higher doses significantly increase anticholinergic side effects, particularly problematic in patients with prostatic hypertrophy, elevated intraocular pressure, or baseline cognitive impairment 5
Renal Impairment
- Dose should be halved in patients with moderate to severe renal impairment 4
- Hydroxyzine should be avoided in severe renal impairment (creatinine clearance < 10 mL/min) 4
Hepatic Impairment
- Avoid in severe liver disease as sedating effects are inappropriate and may precipitate complications 4
Safety and Tolerability Profile
Common Side Effects
- Transient drowsiness/sleepiness occurs in 28-36% of patients, typically appearing during the first week and progressively diminishing with continued treatment 6, 3
- Anticholinergic effects including dry mouth (14%) and blurred vision, particularly concerning in elderly patients 5, 6
- Weight gain (12%), weakness (18%), and headache (6%) reported in clinical trials 6
Contraindications and Precautions
- Contraindicated in early pregnancy, particularly first trimester, as it is the only antihistamine specifically contraindicated during early pregnancy stages 4
- Should be avoided during lactation when possible 4
- Discontinue at least 6 days before skin prick testing due to antihistaminic effects 4
Dose Adjustment Strategy
Dosage should be adjusted according to individual patient response to therapy 1. The evidence supports starting at standard doses and titrating based on:
- Clinical efficacy in symptom control
- Tolerability of side effects, particularly sedation
- Patient-specific factors including age, renal function, and hepatic function
- Concomitant medications that may interact or potentiate sedation